UNSPSC 51451612: Fenbendazole for veterinary use

This classification denotes an antihelminthic agent with the molecular formula C15H13N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 621BVT9M36, chemically known as 2-benzimidazolecarbamic acid, 5-(phenylthio)-, methyl ester but more generally known as fenbendazole, which bears US NIH Compound Identifier 3334. European Medicines Agency schedules Fenbendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07541MIG.

UNSPSC 51451612 Fenbendazole for veterinary use is a Commodity code, but recent state and local procurement activity under this code shows no alignment with the nominal scope; the opportunities posted are for human pharmaceuticals, medical supplies, and naloxone distribution rather than veterinary anthelmintics. The few recent solicitations tagged to this code are Seminole County, Florida's competitive bid for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB 60459723LAS, response due July 26, 2023); the City of Tampa's sealed-bid procurement for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 (ITB 26P00145, response due March 13, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and over-the-counter products distributed to state and local facilities including Oregon (RFP S1070000015802, response due March 26, 2026). The Texas Health and Human Services Commission also issued an RFI (HHS0017013) in April 2026 exploring direct-to-manufacturer prescription fulfillment capabilities, though this is exploratory procurement intelligence rather than a formal solicitation.

The issuing bodies span county health services, municipal fire departments, state cooperative purchasing coalitions, and state health agencies. Geographic activity centers on Florida, Texas, Minnesota, and Oregon. The code exhibits minimal relevant recent activity; the posted opportunities are plainly outside fenbendazole's veterinary pharmaceutical scope and suggest either cataloging errors or that this commodity code is not actively used for state and local purchases in its intended market. Business development professionals should verify whether fenbendazole procurement appears under alternate codes or remains dormant in state and local procurement volumes.